Role of Neurofilament Light Chain as a Potential Biomarker for Alzheimer's Disease: A Correlative Meta-Analysis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of Neurofilament Light Chain as a Potential Biomarker for Alzheimer's Disease: A Correlative Meta-Analysis
Authors
Keywords
-
Journal
Frontiers in Aging Neuroscience
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-09-13
DOI
10.3389/fnagi.2019.00254
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration
- (2019) Nicholas J. Ashton et al. Acta Neuropathologica Communications
- Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer’s disease
- (2019) Philip S. J. Weston et al. Alzheimers Research & Therapy
- Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum
- (2019) Isabelle Bos et al. Alzheimers & Dementia
- Diagnostic performance of new and classic CSF biomarkers in age-related dementias
- (2019) Francesca Marchegiani et al. Aging-US
- Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study
- (2019) Alberto Lleó et al. Alzheimers & Dementia
- Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease
- (2019) Niklas Mattsson et al. JAMA Neurology
- Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ 1–42 , total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40
- (2018) Harald Hampel et al. Alzheimers & Dementia
- Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases
- (2018) Inga Zerr et al. Alzheimers & Dementia
- From Cerebrospinal Fluid to Blood: The Third Wave of Fluid Biomarkers for Alzheimer’s Disease
- (2018) Henrik Zetterberg et al. JOURNAL OF ALZHEIMERS DISEASE
- Association of Plasma Neurofilament Light Chain with Neocortical Amyloid-β Load and Cognitive Performance in Cognitively Normal Elderly Participants
- (2018) Pratishtha Chatterjee et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal Fluid and Plasma Levels of Inflammation Differentially Relate to CNS Markers of Alzheimer’s Disease Pathology and Neuronal Damage
- (2018) Brianne M. Bettcher et al. JOURNAL OF ALZHEIMERS DISEASE
- Neurodegeneration, synaptic dysfunction, and gliosis are phenotypic of Alzheimer dementia
- (2018) Andrew P. Merluzzi et al. NEUROLOGY
- Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic
- (2018) Ross W. Paterson et al. Alzheimers Research & Therapy
- Cerebrospinal Fluid Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Combination with Subcortical and Cortical Biomarkers in Vascular Dementia and Alzheimer's Disease
- (2018) Maria Bjerke et al. JOURNAL OF ALZHEIMERS DISEASE
- Evaluation of Cerebrospinal Fluid Neurofilament Light Chain as a Routine Biomarker in a Memory Clinic
- (2018) Matías Niikado et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study
- (2018) Juan Fortea et al. LANCET NEUROLOGY
- Serum neurofilament light chain in behavioral variant frontotemporal dementia
- (2018) Petra Steinacker et al. NEUROLOGY
- Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
- (2018) Piotr Lewczuk et al. Alzheimers Research & Therapy
- Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease
- (2018) Yung-Shuan Lin et al. Scientific Reports
- Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer’s disease
- (2018) Raquel Sánchez-Valle et al. Alzheimers Research & Therapy
- The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease
- (2018) Nicholas M. Vogt et al. Alzheimers Research & Therapy
- Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders
- (2018) Bob Olsson et al. JAMA Neurology
- Alzheimer's disease
- (2017) C. A. Lane et al. EUROPEAN JOURNAL OF NEUROLOGY
- Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls
- (2017) Aylin Yilmaz et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Association between cerebrospinal fluid and plasma neurodegeneration biomarkers with brain atrophy in Alzheimer's disease
- (2017) Joana B. Pereira et al. NEUROBIOLOGY OF AGING
- Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer's disease
- (2017) Simone Lista et al. NEUROCHEMISTRY INTERNATIONAL
- Serum neurofilament light in familial Alzheimer disease
- (2017) Philip S.J. Weston et al. NEUROLOGY
- Plasma neurofilament light chain levels in Alzheimer’s disease
- (2017) Wenjun Zhou et al. NEUROSCIENCE LETTERS
- Race modifies the relationship between cognition and Alzheimer’s disease cerebrospinal fluid biomarkers
- (2017) Jennifer C. Howell et al. Alzheimers Research & Therapy
- Cerebrospinal Fluid Biomarker for Alzheimer Disease Predicts Postoperative Cognitive Dysfunction
- (2016) Lisbeth Evered et al. ANESTHESIOLOGY
- Cerebrospinal Fluid Markers of Alzheimer’s Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer’s Disease
- (2016) Kelsey E. Melah et al. JOURNAL OF ALZHEIMERS DISEASE
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression
- (2016) Henrik Zetterberg et al. JAMA Neurology
- Alzheimer's disease — Recent biomarker developments in relation to updated diagnostic criteria
- (2015) Kina Höglund et al. CLINICA CHIMICA ACTA
- CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival
- (2014) T. Skillback et al. NEUROLOGY
- Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia
- (2013) Maria Landqvist Waldö et al. BMC Neurology
- Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases
- (2013) Johanna Gaiottino et al. PLoS One
- Cerebrospinal fluid biomarkers for Alzheimer disease and subcortical axonal damage in 5,542 clinical samples
- (2013) Tobias Skillbäck et al. Alzheimers Research & Therapy
- CSF Biomarkers for Amyloid and Tau Pathology in Alzheimer's Disease
- (2011) Hanna Rosenmann JOURNAL OF MOLECULAR NEUROSCIENCE
- Alzheimer's disease
- (2011) Clive Ballard et al. LANCET
- Serial CSF sampling in Alzheimer's disease: specific versus non-specific markers
- (2011) Maartje I. Kester et al. NEUROBIOLOGY OF AGING
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search